Clorazepate is a Schedule IV controlled substance in the United States, as classified by the Drug Enforcement Administration. Sold under the brand name Tranxene, it belongs to the benzodiazepine family alongside more familiar names like diazepam (Valium) and alprazolam (Xanax), all of which share the same Schedule IV designation. This classification means clorazepate has a recognized medical use but also carries a real risk of dependence and misuse.
What Schedule IV Means in Practice
The DEA uses five scheduling tiers. Schedule I includes drugs with no accepted medical use and high abuse potential. Schedule IV sits near the lower end of that scale, meaning clorazepate is considered to have a relatively low abuse potential compared to substances in Schedules I through III, but it still comes with legal restrictions that affect how you get and refill it.
Federal law limits Schedule IV prescriptions to a maximum of five refills within six months from the date the prescription was originally written. After that window closes, your prescriber must write an entirely new prescription. You cannot stockpile refills or carry them over past the six-month mark. Some states impose additional restrictions on top of the federal rules, so local pharmacy policies may vary.
What Clorazepate Is Prescribed For
Clorazepate has three FDA-approved uses: management of anxiety disorders, adjunctive treatment of partial seizures, and short-term relief of symptoms during acute alcohol withdrawal. For anxiety, it is typically intended for short-term use rather than indefinite daily treatment, a pattern common across benzodiazepines.
How Clorazepate Works in the Body
Like all benzodiazepines, clorazepate enhances the activity of GABA, the brain’s main calming chemical messenger. When GABA activity increases, nerve cells become less excitable, which produces the sedative, anti-anxiety, and anticonvulsant effects the drug is prescribed for. One distinctive feature of clorazepate is that your body converts it almost immediately into its active form, a compound called nordiazepam. Essentially no unchanged clorazepate circulates in your bloodstream. Nordiazepam has a long half-life of roughly 40 to 50 hours, meaning it takes about two days for your body to clear half of a single dose. That long duration helps maintain steady effects but also means the drug builds up with repeated use.
Abuse Potential Compared to Other Benzodiazepines
Not all benzodiazepines carry equal misuse risk, even though they share the same legal classification. Research from the American Academy of Family Physicians shows that clorazepate has lower reinforcing effects than many of its relatives. The benzodiazepines most likely to be misused tend to be those that hit the brain quickly (highly fat-soluble drugs like diazepam) or those that are both high-potency and short-acting (like alprazolam and lorazepam). Clorazepate is a low-potency, long-acting benzodiazepine, a combination that generally makes it less appealing for recreational misuse.
That said, “lower risk” is not the same as “no risk.” Any benzodiazepine can produce physical dependence with regular use. The speed at which dependence develops depends on three factors: dose, duration, and the drug’s potency. A person taking a high dose of a high-potency benzodiazepine like alprazolam can develop dependence in as little as one to two months. With a low-potency, long-acting agent like clorazepate, that timeline is generally longer, but dependence still occurs with sustained use.
Tolerance and Dependence
Tolerance to benzodiazepines develops at different rates depending on the effect. Tolerance to the sleep-inducing effects tends to appear quickly, sometimes within days to weeks. Tolerance to the anxiety-reducing effects builds more slowly, but there is little evidence that benzodiazepines maintain their full effectiveness beyond four to six months of daily use. This is one reason prescribers typically aim for the shortest effective course of treatment.
Physical dependence is a separate issue from misuse. Even someone taking clorazepate exactly as prescribed can become physically dependent, meaning their body adapts to the drug’s presence and reacts negatively when it is removed. Because nordiazepam lingers in the body for days, withdrawal symptoms from clorazepate tend to emerge more slowly than with short-acting benzodiazepines. Common withdrawal symptoms across the class include rebound anxiety, insomnia, irritability, tremor, and in severe cases, seizures. Stopping abruptly after weeks or months of use is not safe. A gradual taper, supervised by a prescriber, is the standard approach.
Risks of Combining With Opioids
One of the most serious safety concerns with any benzodiazepine, clorazepate included, is the danger of combining it with opioid medications. Both drug classes slow breathing, and together they can suppress respiration to a life-threatening degree. The FDA has placed its strongest safety warning on benzodiazepine labels to flag this specific risk. If you are prescribed clorazepate and also take any opioid pain medication, that combination requires careful monitoring.